A Multi-Center, Qualitative Assessment of Pediatrician and Maternal Perspectives on Rotavirus Vaccines and the Detection of Porcine circovirus

BMC Pediatrics

Volumn 11, Issue , 2011, Pages

  Payne, Daniel C ^a   Humiston, Sharon ^b,c   Opel, Douglas ^d   Kennedy, Allison ^a   Wikswo, Mary ^a   Downing, Kimberly ^e   Klein, Eileen J ^d   Kobayashi, Ana ^d   Locke, David ^f   Albertin, Christina ^b   Chesley, Claudia ^a   Staat, Mary A ^f  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adventitious virus; Communication development; Focus groups; Pediatricians; Porcine circovirus (pcv); Rotarix ; Rotateq ; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE; VIRUS DNA;

ARTICLE; ATTITUDE; CIRCOVIRUS; CLINICAL ARTICLE; DIARRHEA; DRUG LABELING; DRUG SAFETY; FOCUS GROUP; HUMAN; INTERVIEW; MOTHER; NONHUMAN; PEDIATRICIAN; PERCEPTION; QUALITATIVE ANALYSIS; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; ROTAVIRUS INFECTION; SCORING SYSTEM; SWINE; VACCINATION; VACCINE PRODUCTION; VIRUS DETECTION; ADULT; ATTITUDE TO HEALTH; CLINICAL TRIAL; DECISION MAKING; DRUG CONTAMINATION; FEMALE; GASTROENTERITIS; GENETICS; HEALTH PERSONNEL ATTITUDE; HUMAN RELATION; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; ISOLATION AND PURIFICATION; MALE; MULTICENTER STUDY; PEDIATRICS; PHYSICIAN; PSYCHOLOGICAL ASPECT; TRUST;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CIRCOVIRUS; COMMUNICATION; DECISION MAKING; DRUG CONTAMINATION; FEMALE; FOCUS GROUPS; GASTROENTERITIS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MOTHERS; PEDIATRICS; PHYSICIANS; PROFESSIONAL-FAMILY RELATIONS; ROTAVIRUS VACCINES; TRUST; YOUNG ADULT;

EID: 80053343405     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-11-83     Document Type: Article

References (29)

1. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33. 10.1056/NEJMoa052664, 16394299.
2. Vesikari T, Itzler R, Matson DO, Santosham M, Christie CD, Coia M, Cook JR, Koch G, Heaton PM. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis 2007, 11(Suppl 2):S29-35.
3. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354:11-22. 10.1056/NEJMoa052434, 16394298.
4. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O'Ryan M, Gillard P, Bouckenooghe A, . the Human Rotavirus Vaccine Study Group Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371:1181-9. 10.1016/S0140-6736(08)60524-3, 18395579, the Human Rotavirus Vaccine Study Group.
5. Block SL, Vesikari T, Goveia MG, Rivers SB, Adeyi BA, Dallas MJ, Bauder J, Boslego JW, Heaton PM. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics 2007, 119:11-8. 10.1542/peds.2006-2058, 17200266.
6. Belongia E, Irving S, Shui I. Rapid cycle analysis of pentavalent rotavirus (RotaTeq) vaccine safety in the Vaccine Safety Datalink population: preliminary results. Presented at: Advisory Committee on Immunization Practices. 2008, Atlanta, GA.
7. Centers for Disease Control and Prevention Reduction in rotavirus after vaccine introduction -- United States, 2000-2009. MMWR 2009, 58:1146-9. Centers for Disease Control and Prevention.
8. Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, Parashar UD. Decline and change in seasonal patterns of rotavirus activity after the introduction of rotavirus vaccine in the United States. Pediatrics 2009, 124:465-71. 10.1542/peds.2008-3528, 19581260.
9. Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, Gardner S, Delwart EL. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84:6033-40. 10.1128/JVI.02690-09, 2876658, 20375174.
10. Li L, Kapoor A, Slikas B, Bamidele OS, Wang C, Shaukat S, Masroor MA, Wilson ML, Ndjango JB, Peeters M, Gross-Camp ND, Muller MN, Hahn BH, Wolfe ND, Triki H, Bartkus J, Zaidi SZ, Delwart E. Multiple, diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J Virol 2010, 84:1674-82. 10.1128/JVI.02109-09, 2812408, 20007276., http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812408/?tool=pubmed
11. Kuehn BM. FDA: Benefits of rotavirus vaccination outweigh potential contamination risk. JAMA 2010, 304:30-1. 10.1001/jama.2010.863, 20606142., http://jama.ama-assn.org/cgi/content/full/304/1/30
12. Friedland L. Rotarix® (Rotavirus Vaccine, Live Oral): GSK's PCV1 Investigation. Presented at: Advisory Committee on Immunization Practices. 2010, Atlanta, GA., http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun10/13-3-rota.pdf
13. Ranucci C. RotaTeq® (Rotavirus Vaccine, Live Oral, Pentavalent): Update on Porcine Circovirus (PCV). Presented at: Advisory Committee on Immunization Practices 2010, Atlanta, GA., http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-oct10/12-6-rota-PCVupdate.pdf
14. Hussain AI, Johnson JA, Da Silva Freire M, Heniene W. Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients. J Virol 2007, 77:1105-11.
15. Engels E. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research. Expert Rev Vaccines 2005, 4:197-206. 10.1586/14760584.4.2.197, 15889993.
16. Hussain AI, Shanmugam V, Switzer WM, Tsang SX, Fadly A, Thea D, Helfand R, Bellini WJ, Folks TM, Heneine W. Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg Infect Dis 2001, 7:66-72. 10.3201/eid0701.010111, 2631681, 11266296.
17. Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook 1994, Thousand Oaks: Sage Publications, Strauss, 2.
18. Corbin AJ. Basics of qualitative research: Techniques and procedures for developing grounded theory 1998, Thousand Oaks, CA: Sage Publications, Inc, 2.
19. U.S. Centers for Disease Control and Prevention website Vaccines for Children (VFC) Program. Accessed November 16, 2010, U.S. Centers for Disease Control and Prevention website., http://www.cdc.gov/vaccines/programs/vfc/default.htm
20. The Pink Sheet website Vaccine Manufacturers Need Plans To Cut Adventitious Agents By October. Accessed September 7, 2010, The Pink Sheet website., http://thepinksheet.elsevierbi.com
21. Food and Drug Administration Product approval information-licensing action, package insert: RotaTeq™ (Rotavirus Vaccine, Live, Oral, Pentavalant), Merck and Co., Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; revised. 2010, Food and Drug Administration.
22. Food and Drug Administration Product approval information-licensing action, package insert: Rotarix® (Rotavirus Vaccine, Live, Oral, Monovalant), GlaxoSmithKline Biologicals. 2010, Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; revised, Food and Drug Administration.
23. McClenahan SD, Krause PR, Uhlenhaut C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29:4745-53. 10.1016/j.vaccine.2011.04.087, 21569811.
24. Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006, 118:e1287-92. 10.1542/peds.2006-0923, 17079529.
25. Gust DA, Kennedy A, Shui I, Smith PJ, Novak G, Pickering LK. Parent attitudes toward immunizations and healthcare providers: the role of information. Am J Prev Med 2005, 29:105-12. 10.1016/j.amepre.2005.04.010, 16005806.
26. Taylor JA, Darden PM, Slora E, Hasemeier CM, Asmussen L, Wasserman R. The influence of provider behavior, parental characteristics, and a public policy initiative on the immunization status of children followed by private pediatricians: a study from Pediatric Research in Office Settings. Pediatrics 1997, 99:209-15.
27. Gust DA, Woodruff R, Kennedy AM, Brown C, Sheedy K, Hibbs B. Parental perceptions surrounding risks and benefits of immunization. Semin Pediatr Infect Dis 2003, 14:207-12. 10.1016/S1045-1870(03)00035-9, 12913833.
28. Taylor JA, Newman RD. Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research Network. Arch Pediatr Adolesc Med 2000, 154:302-6.
29. Sturm LA, Mays RM, Zimet GD. Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr 2005, 26:441-52. 10.1097/00004703-200512000-00009, 16344662.